| UniProt ID | ESR1_RAT | |
|---|---|---|
| UniProt AC | P06211 | |
| Protein Name | Estrogen receptor | |
| Gene Name | Esr1 | |
| Organism | Rattus norvegicus (Rat). | |
| Sequence Length | 600 | |
| Subcellular Localization | Nucleus . Cytoplasm. Golgi apparatus. Cell membrane. Colocalizes with ZDHHC7 and ZDHHC21 in the Golgi apparatus where most probably palmitoylation occurs. Associated with the plasma membrane when palmitoylated.. | |
| Protein Description | Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3 (By similarity).. | |
| Protein Sequence | MTMTLHTKASGMALLHQIQGNELEPLNRPQLKMPMERALGEVYVDNSKPAVFNYPEGAAYEFNAAAAAAAAGASAPVYGQSSITYGPGSEAAAFGANSLGAFPQLNSVSPSPLMLLHPPPHVSPFLHPHGHQVPYYLENEPSAYAVRDTGPPAFYRSNSDNRRQNGRERLSSSSEKGNMIMESAKETRYCAVCNDYASGYHYGVWSCEGCKAFFKRSIQGHNDYMCPATNQCTIDKNRRKSCQACRLRKCYEVGMMKGGIRKDRRGGRMLKHKRQRDDLEGRNEMGTSGDMRAANLWPSPLVIKHTKKNSPALSLTADQMVSALLDAEPPLIYSEYDPSRPFSEASMMGLLTNLADRELVHMINWAKRVPGFGDLNLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKINDTLIHLMAKAGLTLQQQHRRLAQLLLILSHIRHMSNKGMEHLYNMKCKNVVPLYDLLLEMLDAHRLHAPASRMGVPPEEPSQSQLTTTSSTSAHSLQTYYIPPEAEGFPNTI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | O-linked_Glycosylation | MTLHTKASGMALLHQ CEEECHHHHHHHHHH | 30.56 | - | |
| 109 | Phosphorylation | FPQLNSVSPSPLMLL CCCCCCCCCCCEEEC | 21.34 | - | |
| 111 | Phosphorylation | QLNSVSPSPLMLLHP CCCCCCCCCEEECCC | 24.14 | - | |
| 123 | Phosphorylation | LHPPPHVSPFLHPHG CCCCCCCCCCCCCCC | 13.60 | 12388160 | |
| 172 | Phosphorylation | NGRERLSSSSEKGNM CHHHHCCCCCHHCCC | 42.34 | - | |
| 251 | Phosphorylation | ACRLRKCYEVGMMKG HHHHHHHHHHHCCCC | 19.38 | - | |
| 265 | Asymmetric dimethylarginine | GGIRKDRRGGRMLKH CCCCCCCCCCCCCCC | 63.15 | - | |
| 265 | Methylation | GGIRKDRRGGRMLKH CCCCCCCCCCCCCCC | 63.15 | - | |
| 452 | S-palmitoylation | LQGEEFVCLKSIILL CCCCCEEEEEEEHHH | 4.87 | - | |
| 455 | Phosphorylation | EEFVCLKSIILLNSG CCEEEEEEEHHHCCC | 11.25 | 16641100 | |
| 469 | Phosphorylation | GVYTFLSSTLKSLEE CHHHHHHHHHHHHHH | 39.65 | 16641100 | |
| 542 | Phosphorylation | CKNVVPLYDLLLEML CCCCCHHHHHHHHHH | 9.85 | - | |
| 576 | O-linked_Glycosylation | SQSQLTTTSSTSAHS CCCCCCCCCCCCCCE | 18.55 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 109 | S | Phosphorylation | Kinase | CDK2 | Q63699 | Uniprot |
| 111 | S | Phosphorylation | Kinase | CDK2 | Q63699 | Uniprot |
| 172 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
| 542 | Y | Phosphorylation | Kinase | TYR-KINASES | - | Uniprot |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 123 | S | Phosphorylation |
| - |
| 265 | R | Methylation |
| - |
| 265 | R | Methylation |
| - |
| 452 | C | Palmitoylation |
| - |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ESR1_RAT !! | ||||||
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...